| # | Drug | Count |
|---|---|---|
| 0 | DABRAFENIB | 4 |
| 1 | TRAMETINIB | 4 |
| 2 | VEMURAFENIB | 3 |
| 3 | ETANERCEPT | 2 |
| 4 | INFLIXIMAB | 2 |
| 5 | SILDENAFIL CITRATE | 2 |
| 6 | ADALIMUMAB | 1 |
| 7 | ADALIMUMAB-AATY | 1 |
| 8 | ADALIMUMAB-ADAZ | 1 |
| 9 | ADALIMUMAB-FKJP | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DINUTUXIMAB | 1 | 0.0012 |
| 1 | VEMURAFENIB | 3 | 0.0003 |
| 2 | COBIMETINIB | 1 | 0.0002 |
| 3 | DABRAFENIB | 4 | 0.0002 |
| 4 | TRAMETINIB | 4 | 0.0002 |
| 5 | DASATINIB | 1 | 0.0001 |
| 6 | GOLIMUMAB | 1 | 0.0001 |
| 7 | SIROLIMUS | 1 | 0.0001 |
| 8 | TEMOZOLOMIDE | 1 | 0.0000 |
| 9 | ADALIMUMAB-FKJP | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 1 | 0.0009 |
| 1 | Integrin Receptor Antagonist [EPC] | 1 | 0.0000 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1 | 0.0000 |
| 3 | Phosphodiesterase 5 Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Kinase Inhibitor [EPC] | 4 | 0.0000 |
| 5 | Alkylating Drug [EPC] | 1 | 0.0000 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 1 | 0.0000 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 3 | 0.0000 |
| 8 | Corticosteroid [EPC] | 2 | 0.0000 |
| 9 | Benzodiazepine [EPC] | 1 | 0.0000 |